Terms: = Head and neck cancer AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR AND Prognosis
12 results:
1. "Examining the link between tooth agenesis and papillary thyroid cancer: is there a risk factor?" Observational study.
Matošić Ž; Šimunović L; Jukić T; Granić R; Meštrović S
Prog Orthod; 2024 Mar; 25(1):12. PubMed ID: 38523193
[TBL] [Abstract] [Full Text] [Related]
2. Molecular characterisation of tumours of the lacrimal apparatus.
Vibert R; Cyrta J; Girard E; Vacher S; Dupain C; Antonio S; Wong J; Baulande S; De Sousa JMF; Vincent-Salomon A; Masliah-Planchon J; Girard N; Le Tourneau C; Kamal M; Bièche I
Histopathology; 2023 Dec; 83(6):925-935. PubMed ID: 37706251
[TBL] [Abstract] [Full Text] [Related]
3. The Emerging Role of Circulating Tumor DNA in Non-Colorectal Gastrointestinal cancers.
Lee MS; Kaseb AO; Pant S
Clin Cancer Res; 2023 Sep; 29(17):3267-3274. PubMed ID: 37092904
[TBL] [Abstract] [Full Text] [Related]
4. fgfr2-amplified tumor clones are markedly heterogeneously distributed in carcinomas of the upper gastrointestinal tract.
Albin J; Fahrig L; Siemanowski J; Rehkaemper J; Gebauer F; Zander T; Buettner R; Bruns CJ; Schroeder W; Alakus H; Hieggelke L; Quaas A
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5289-5300. PubMed ID: 36416959
[TBL] [Abstract] [Full Text] [Related]
5. Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric cancers.
Chaudhary SP; Kwak EL; Hwang KL; Lennerz JK; Corcoran RB; Heist RS; Russo AL; Parikh A; Borger DR; Blaszkowsky LS; Faris JE; Murphy JE; Azzoli CG; Roeland EJ; Goyal L; Allen J; Mullen JT; Ryan DP; Iafrate AJ; Klempner SJ; Clark JW; Hong TS
Oncologist; 2020 Nov; 25(11):e1691-e1700. PubMed ID: 32820577
[TBL] [Abstract] [Full Text] [Related]
6. The Integrated Analyses of Driver Genes Identify Key Biomarkers in Thyroid cancer.
Xu Q; Song A; Xie Q
Technol Cancer Res Treat; 2020; 19():1533033820940440. PubMed ID: 32812852
[TBL] [Abstract] [Full Text] [Related]
7. Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes in head and neck squamous cell carcinoma.
Jin Y; Qin X
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894857
[TBL] [Abstract] [Full Text] [Related]
8. The efficacy of cisplatin on nasopharyngeal carcinoma cells may be increased via the downregulation of fibroblast growth factor receptor 2.
Pu L; Su L; Kang X
Int J Mol Med; 2019 Jul; 44(1):57-66. PubMed ID: 31115494
[TBL] [Abstract] [Full Text] [Related]
9. The Mutational Profile of Unicystic Ameloblastoma.
Heikinheimo K; Huhtala JM; Thiel A; Kurppa KJ; Heikinheimo H; Kovac M; Kragelund C; Warfvinge G; Dawson H; Elenius K; Ristimäki A; Baumhoer D; Morgan PR
J Dent Res; 2019 Jan; 98(1):54-60. PubMed ID: 30216733
[TBL] [Abstract] [Full Text] [Related]
10. Resistance to cetuximab in EGFR-overexpressing esophageal squamous cell carcinoma xenografts due to fgfr2 amplification and overexpression.
Zhang Y; Pan T; Zhong X; Cheng C
J Pharmacol Sci; 2014; 126(1):77-83. PubMed ID: 25242085
[TBL] [Abstract] [Full Text] [Related]
11. Gene amplification of EGFR, HER2, fgfr2 and MET in esophageal squamous cell carcinoma.
Kato H; Arao T; Matsumoto K; Fujita Y; Kimura H; Hayashi H; Nishiki K; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Imano M; Imamoto H; Yasuda T; Okuno K; Shiozaki H; Nishio K
Int J Oncol; 2013 Apr; 42(4):1151-8. PubMed ID: 23426935
[TBL] [Abstract] [Full Text] [Related]
12. Fibroblast growth factor receptor inhibition synergizes with Paclitaxel and Doxorubicin in endometrial cancer cells.
Byron SA; Loch DC; Pollock PM
Int J Gynecol Cancer; 2012 Nov; 22(9):1517-26. PubMed ID: 23060048
[TBL] [Abstract] [Full Text] [Related]
